Cargando…
Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency
Antibody drug conjugates (ADCs) have recently been proven to be highly potent anti-tumor drugs, typically exceeding the efficacy of conventional monoclonal antibodies (mAbs). ADCs are currently produced by chemical conjugation of a small-molecule toxin to the mAb through lysine or cysteine side chai...
Autores principales: | Beerli, Roger R., Hell, Tamara, Merkel, Anna S., Grawunder, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488448/ https://www.ncbi.nlm.nih.gov/pubmed/26132162 http://dx.doi.org/10.1371/journal.pone.0131177 |
Ejemplares similares
-
Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells
por: Hellmann, Ina, et al.
Publicado: (2018) -
In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates
por: Jackson, Dowdy, et al.
Publicado: (2014) -
Sortase-Mediated Site-Specific Modification of Interleukin-2
for the Generation of a Tumor-Targeting Acetazolamide–Cytokine
Conjugate
por: Gouyou, Baptiste, et al.
Publicado: (2020) -
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
por: D’Amico, Lucia, et al.
Publicado: (2019) -
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
por: Dovgan, Igor, et al.
Publicado: (2020)